Frontiers in endocrinology · 2026
Influence of vitamin D supplementation on ovarian reserve as reflected by anti-Müllerian hormone levels: a meta-analysis of randomized controlled trials.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fang Sitian, Li Yijia, Fan Xinyu, Zheng Liping
Аннотация
BACKGROUND: Vitamin D has been implicated in ovarian physiology, yet its effect on ovarian reserve remains controversial. We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the influence of vitamin D supplementation on ovarian reserve as indicated by serum anti-Müllerian hormone (AMH) levels.
METHODS: PubMed, Cochrane Library, Embase, Web of Science, Wanfang, and CNKI were searched for RCTs comparing vitamin D supplementation with placebo or no intervention on AMH in women of reproductive age. The pooled effect was summarized as standardized mean difference (SMD) using a random-effects model by incorporating the influence of potential heterogeneity.
RESULTS: Eleven RCTs with 992 women were included. Overall, vitamin D supplementation did not significantly affect serum AMH levels (SMD: -0.20; 95% CI: -0.48 to 0.08; p = 0.16), with substantial heterogeneity (I² = 77%, p < 0.001). Subgroup analysis showed no significant effect in double-blind trials but a reduction in AMH in open-label trials (p for subgroup difference = 0.02). A significant interaction was observed according to baseline AMH level (p = 0.003), with a reduction in studies where baseline AMH > 6 ng/mL (SMD: -0.55; 95% CI: -0.87 to -0.23). No significant subgroup differences were found by age, baseline 25(OH)D, vitamin D dose, treatment duration, or assay method.
CONCLUSIONS: Current randomized evidence suggests that vitamin D supplementation was not likely to alter AMH levels in reproductive-aged women overall. The certainty of evidence was moderate, and findings should be interpreted cautiously given substantial heterogeneity.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier CRD420261329210.
METHODS: PubMed, Cochrane Library, Embase, Web of Science, Wanfang, and CNKI were searched for RCTs comparing vitamin D supplementation with placebo or no intervention on AMH in women of reproductive age. The pooled effect was summarized as standardized mean difference (SMD) using a random-effects model by incorporating the influence of potential heterogeneity.
RESULTS: Eleven RCTs with 992 women were included. Overall, vitamin D supplementation did not significantly affect serum AMH levels (SMD: -0.20; 95% CI: -0.48 to 0.08; p = 0.16), with substantial heterogeneity (I² = 77%, p < 0.001). Subgroup analysis showed no significant effect in double-blind trials but a reduction in AMH in open-label trials (p for subgroup difference = 0.02). A significant interaction was observed according to baseline AMH level (p = 0.003), with a reduction in studies where baseline AMH > 6 ng/mL (SMD: -0.55; 95% CI: -0.87 to -0.23). No significant subgroup differences were found by age, baseline 25(OH)D, vitamin D dose, treatment duration, or assay method.
CONCLUSIONS: Current randomized evidence suggests that vitamin D supplementation was not likely to alter AMH levels in reproductive-aged women overall. The certainty of evidence was moderate, and findings should be interpreted cautiously given substantial heterogeneity.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier CRD420261329210.